These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3082776)

  • 1. Persistent suppression of humoral and cell-mediated immunity in mice following exposure to the polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a]anthracene.
    Ward EC; Murray MJ; Lauer LD; House RV; Dean JH
    Int J Immunopharmacol; 1986; 8(1):13-22. PubMed ID: 3082776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice--II. Altered cell-mediated immunity and tumor resistance.
    Dean JH; Ward EC; Murray MJ; Lauer LD; House RV; Stillman W; Hamilton TA; Adams DO
    Int J Immunopharmacol; 1986; 8(2):189-98. PubMed ID: 3086244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of dimethylbenzanthracene-induced immunotoxicity.
    Dean JH; Ward EC; Murray MJ; Lauer LD; House RV
    Clin Physiol Biochem; 1985; 3(2-3):98-110. PubMed ID: 3924465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of splenic lymphocyte function by 7,12-dimethylbenz[a]anthracene (DMBA) in vitro.
    Thurmond LM; House RV; Lauer LD; Dean JH
    Toxicol Appl Pharmacol; 1988 May; 93(3):369-77. PubMed ID: 2835829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression following 7,12-dimethylbenz[a]anthracene exposure in B6C3F1 mice. I. Effects on humoral immunity and host resistance.
    Ward EC; Murray MJ; Lauer LD; House RV; Irons R; Dean JH
    Toxicol Appl Pharmacol; 1984 Sep; 75(2):299-308. PubMed ID: 6433512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression following exposure to 7,12-dimethylbenz[a]anthracene (DMBA) in Ah-responsive and Ah-nonresponsive mice.
    Thurmond LM; Lauer LD; House RV; Cook JC; Dean JH
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):450-60. PubMed ID: 3122368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of murine cytotoxic T-lymphocyte induction following exposure to 7,12-dimethylbenz[A]anthracene: dysfunction of antigen recognition.
    House RV; Pallardy MJ; Dean JH
    Int J Immunopharmacol; 1989; 11(2):207-15. PubMed ID: 2495255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent suppression of humoral immunity produced by 7,12-dimethylbenz(A)anthracene (DMBA) in B6C3F1 mice: correlation with changes in spleen cell surface markers detected by flow cytometry.
    Burchiel SW; Hadley WM; Barton SL; Fincher RH; Lauer LD; Dean JH
    Int J Immunopharmacol; 1988; 10(4):369-76. PubMed ID: 3139575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of T-helper cell function in mice following exposure to the carcinogen 7,12-dimethylbenz[a]anthracene and its restoration by interleukin-2.
    House RV; Lauer LD; Murray MJ; Dean JH
    Int J Immunopharmacol; 1987; 9(1):89-97. PubMed ID: 2953689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 1B1 is required for 7,12-dimethylbenz(a)-anthracene (DMBA) induced spleen cell immunotoxicity.
    Gao J; Lauer FT; Dunaway S; Burchiel SW
    Toxicol Sci; 2005 Jul; 86(1):68-74. PubMed ID: 15843505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsomal expoxide hydrolase is required for 7,12-dimethylbenz[a]anthracene (DMBA)-induced immunotoxicity in mice.
    Gao J; Lauer FT; Mitchell LA; Burchiel SW
    Toxicol Sci; 2007 Jul; 98(1):137-44. PubMed ID: 17442664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone.
    Ladics GS; Kawabata TT; White KL
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):31-44. PubMed ID: 1908145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice.
    Smith DC; Smith MJ; White KL
    J Immunotoxicol; 2010; 7(3):219-31. PubMed ID: 20509767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phencyclidine exposure alters in vitro cellular immune response parameters associated with host defense.
    Thomas PT; House RV; Bhargava HN
    Life Sci; 1993; 53(18):1417-27. PubMed ID: 8231630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and biochemical disposition of 7,12-dimethylbenz[a]anthracene in murine lymphoid cells.
    Thurmond LM; Tucker AN; Rickert DE; Lauer LD; Dean JH
    Chem Biol Interact; 1989; 72(1-2):93-104. PubMed ID: 2510951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
    Pallardy MJ; House RV; Dean JH
    Mol Pharmacol; 1989 Jul; 36(1):128-33. PubMed ID: 2501653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
    Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
    Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxicity of N,N-diethylaniline in mice: effect on natural killer activity, cytotoxic T lymphocyte activity, lymphocyte proliferation response and cellular components of the spleen.
    Li Q; Hirata Y; Piao S; Minami M
    Toxicology; 2000 Sep; 150(1-3):179-89. PubMed ID: 10996674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression by polycyclic aromatic hydrocarbons: a structure-activity relationship in B6C3F1 and DBA/2 mice.
    White KL; Lysy HH; Holsapple MP
    Immunopharmacology; 1985 Jun; 9(3):155-64. PubMed ID: 4040508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective immunosuppression following exposure to a novel anthraquinone, 1,4-bis[(2-aminoethyl)amino]-5,8-dihydroxy-9,10-anthracenedione dihydrochloride (AEAD).
    House RV; Lauer LD; Thurmond LM; Cornacoff JB; Dean JH
    Int J Immunopharmacol; 1989; 11(1):95-101. PubMed ID: 2785091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.